top of page
Genetika+
Develops DNA-based sequencing tools for personalized drug response predictions in depression treatment.
Company Name | Neurotech Category | Market Category | Company Founded Year | Company Location |
|---|---|---|---|---|
Genetika+ | NeuroPharmacology | NeuroBioTechnology | Biotechnology & Biopharmaceutical | 2018 | Jerusalem |
Develops DNA-based sequencing tools for personalized drug response predictions in depression treatment.
bottom of page